ArticleContemporary oncology (Poznan, Poland)2025
Microglandular adenosis associated with triple-negative invasive breast carcinoma - a case report and literature review.
Article in Contemporary oncology (Poznan, Poland), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Microglandular adenosis (MGA) is a rare benign breast condition characterized by disorganized small glands composed of epithelial cells without myoepithelial components. Microglandular adenosis can coexist with invasive breast cancer (IBC), particularly the triple-negative (TN) subtype. Emerging evidence suggests MGA may be a precursor to IBC, supported by shared morphological and molecular features. We present the case of a 66-year-old woman with a palpable mass in the left breast. Initial mammography and biopsy suggested malignancy. The patient underwent breast-conserving surgery with resection of the sentinel lymph node. Histopathological analysis confirmed triple-negative, basal-like invasive breast carcinoma with focal salivary gland-type carcinoma differentiation, likely arising from an MGA-like component. The patient subsequently received adjuvant chemotherapy, and no recurrence was observed after a 30-month follow-up. This case underscores the importance of recognizing MGA as a potential precursor to invasive breast carcinoma, particularly the TN subtype. Increased awareness and the use of comprehensive diagnostic methods are essential for improving patient outcomes and managing the risks associated with MGA, especially in cases that may progress to more aggressive forms of cancer.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.